Bethesda, MD 20892-9806
United States
National Institutes of Health - Vaccine Research Center
ACE2 receptor, endosomal entry, pH-dependent switch, receptor-binding domain (RBD), structural rearrangement, type 1 fusion machine
envelope, glycomics, glycoprotein, gp120, HIV-1
broadly neutralizing antibody, HIV-1 envelope trimer, multidonor antibody class, PCT64, PG9, PGDM1400, PGT145, tyrosine sulfation, V1V2-apex recognition
antibody VRC01, broadly neutralizing antibody, HIV-1 vaccine, somatic hypermutations